BBOTVSCDT• 28 Days (Normalized)
BBOT vs CDT (BridgeBio Oncology Therapeutics Inc. vs CDT Equity Inc.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.09%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
CDT Performance $0.99
-93.58%
CDT Equity Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+37.49 pts
BBOT outperforming by 37.49 percentage points
BBOTCDT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT CDT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | BBOT Price | BBOT Gain (%) | CDT Price | CDT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.09% | $0.99 | -93.58% | +37.49% |
| Oct 01, 2026 | $- | $1.25 | -91.90% | - | |
| Sep 30, 2026 | $4.10 | -53.72% | $1.36 | -91.18% | +37.46% |
| Sep 29, 2026 | $3.92 | -55.76% | $1.45 | -90.60% | +34.84% |
| Sep 28, 2026 | $3.81 | -57.00% | $1.90 | -87.68% | +30.68% |
| Sep 25, 2026 | $3.95 | -55.42% | $2.00 | -87.03% | +31.61% |
| Sep 24, 2026 | $3.99 | -54.97% | $3.03 | -80.39% | +25.42% |
| Sep 23, 2026 | $4.16 | -53.05% | $3.38 | -78.12% | +25.07% |
| Sep 22, 2026 | $4.66 | -47.40% | $3.55 | -76.99% | +29.59% |
| Sep 21, 2026 | $4.66 | -47.40% | $3.85 | -75.04% | +27.64% |
| Sep 18, 2026 | $4.77 | -46.16% | $4.35 | -71.80% | +25.64% |
| Sep 17, 2026 | $4.89 | -44.81% | $4.75 | -69.21% | +24.40% |
| Sep 16, 2026 | $4.76 | -46.28% | $4.95 | -67.91% | +21.63% |
| Sep 15, 2026 | $4.88 | -44.92% | $5.08 | -67.10% | +22.18% |
| Sep 14, 2026 | $5.05 | -43.00% | $5.48 | -64.51% | +21.51% |
Page 1 of 2